Fundraising FoxDeerfield Management Company — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.
BiotechHealthtechAustin, US
Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in
Co-investorsNew Enterprise Associates (NEA)Roche Venture FundClarus VenturesSante Health VenturesSante VenturesWellcome Trust
SentreHeart appears to now redirect to AtriCure, Inc., a medical device company.
BiotechHardwareHealthtechMedical DevicesRedwood City, US
Russell Seiber(Executive Officer, Director)inPam Simons(Executive Officer)inGreg Fung(Executive Officer)Robert Strasser(Executive Officer)in
BoardPhil Young(Director)inVictor Tong(Director)
Co-investorsDecheng CapitalProspect Venture PartnersUS Venture PartnersU.S. Venture PartnersVivo Capital
Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.
BiotechCambridge, US
Nancy Simonian(CEO)Peter Wirth(Director)Mark Alles(Director)Philip Sharp(Director)Richard A. Young(Director)Sue Gail Eckhardt(Director)
Co-investorsAisling CapitalARCH Venture PartnersQuan CapitalAlexandriaAlly Bridge GroupBain Capital+11 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.